Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H22ClNO2 |
Molecular Weight | 343.847 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=CC(=C1)C2CN(CC=C)CCC3=C2C=C(O)C(O)=C3Cl
InChI
InChIKey=HLNOXCRCYMOMLA-UHFFFAOYSA-N
InChI=1S/C20H22ClNO2/c1-3-8-22-9-7-15-16(11-18(23)20(24)19(15)21)17(12-22)14-6-4-5-13(2)10-14/h3-6,10-11,17,23-24H,1,7-9,12H2,2H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/11600103Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/7908949 | https://www.ncbi.nlm.nih.gov/pubmed/11600103
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11600103
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/7908949 | https://www.ncbi.nlm.nih.gov/pubmed/11600103
SKF-83822 is a D1/D5 receptor agonist, which activates D1-like receptors coupled to stimulation of adenyl cyclase (AC), but not phosphoinositide (PI) hydrolysis. SKF-83822 is used as a tool compound to study the role of AC-coupled D1 receptors.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P21728 Gene ID: 1812.0 Gene Symbol: DRD1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/7908949 |
1.7 nM [Ki] | ||
Target ID: P14416 Gene ID: 1813.0 Gene Symbol: DRD2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/1973652 |
71.0 nM [Ki] | ||
Target ID: P21918 Gene ID: 1816.0 Gene Symbol: DRD5 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/24552847 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16682023
In preclinical experiments on monkeys, SKF-83822 was administered intravenously at 0.08 mg/kg.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7908949
Male rats weighing 225-300 g were decapitated, and the striata were dissected on ice, then gently the tissues were gently homogenized at 0°C in 50 mM Tris-maleate buffer (pH 7.4) containing 2 M EGTA. Aliquots of the homogenate were incubated in medium containing Tris-maleate buffer and SKF-83822. Reaction was started by adding [14C]ATP and shaking at 30°C. After 3 min the reaction was terminated in a boiling water bath, the [14C]cyclic AMP formed was separated from unreacted [14C]ATP using alumina and cation exchange resin columns, and the [14C]cyclic AMP content was measured by liquid scintillation counting.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
10020353
Created by
admin on Sat Dec 16 08:03:54 GMT 2023 , Edited by admin on Sat Dec 16 08:03:54 GMT 2023
|
PRIMARY | |||
|
64004
Created by
admin on Sat Dec 16 08:03:54 GMT 2023 , Edited by admin on Sat Dec 16 08:03:54 GMT 2023
|
PRIMARY | |||
|
74115-08-5
Created by
admin on Sat Dec 16 08:03:54 GMT 2023 , Edited by admin on Sat Dec 16 08:03:54 GMT 2023
|
PRIMARY | |||
|
661JNG0144
Created by
admin on Sat Dec 16 08:03:54 GMT 2023 , Edited by admin on Sat Dec 16 08:03:54 GMT 2023
|
PRIMARY | |||
|
DTXSID3043819
Created by
admin on Sat Dec 16 08:03:54 GMT 2023 , Edited by admin on Sat Dec 16 08:03:54 GMT 2023
|
PRIMARY |
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD